Mylan’s generic shingles treatment approved by FDA

PITTSBURGH The Food and Drug Administration has approved Mylan’s version of a drug for complications related to shingles, Mylan said Friday.

The FDA approved Mylan’s gabapentin tablets in the 600 mg and 800 mg strengths. The drug is a generic version of Pfizer’s Neurontin, used to treat postherpetic neuralgia.

Gabapentin tablets had sales of around $174 million during the 12-month period ended in March, according to IMS Health.

Login or Register to post a comment.